Alzinova AB (OSTO:ALZ) FFO


OSTO:ALZ Alzinova AB OSTO:ALZ
21 GF Score
Price kr0.55
! 1 Warning Sign
View Full Analysis

What is Alzinova AB FFO?

FFO (Funds from operations) only applies to REITs.

OSTO:ALZ
21GF Score
Alzinova AB OSTO:ALZ
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alzinova AB Business Description

Other Exchanges 78D:Germany
Address Entreprenorsstraket 10, Molndal, SWE, 431 53
Alzinova AB is a Swedish biotechnology company engaged in the discovery and development of therapeutics for the treatment of Alzheimer's disease. The company is developing ALZ-101, an oligomer-specific therapeutic vaccine currently advancing toward Phase 2 clinical development, and ALZ-201, a monoclonal antibody targeting toxic amyloid-beta (AB) oligomers, which is in preclinical development. The company's proprietary ABCC peptide technology is focused on disease-modifying treatments for Alzheimer's disease.
21GF Score

Get the complete analysis for OSTO:ALZ

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.55
Price